Country for PR: United Kingdom
Contributor: PR Newswire Europe
Wednesday, September 07 2022 - 01:30
MILAN, Sept. 6, 2022 /PRNewswire-AsiaNet/ --

"Human Brains" is the result of an in-depth research process undertaken by 
Fondazione Prada in 2018 in the field of neuroscience. The project has featured 
an online conference dedicated to the study of consciousness, a series of video 
talks by international scientists, philosophers and researchers, and an 
exhibition on the history of brain studies, currently on view in Venice until 
27 November 2022.

The fourth phase of "Human Brains, titled "Preserving the Brain – Forum on 
Neurodegenerative Diseases", will comprise an exhibition (16 September – 10 
October 2022) and a conference (6 and 7 October 2022) at Fondazione Prada's 
Milan premises.

"Preserving the Brain" aims to stimulate an open and critical exchange between 
international scientists and experts on neurodegenerative diseases, such as 
Alzheimer's, Parkinson's, Amyotrophic lateral sclerosis and Multiple sclerosis, 
which are widely spread and as yet incurable.

As stated by Miuccia Prada, President of Fondazione Prada, "For us, this phase 
of the project is particularly significant as it permits a closer understanding 
of scientific research's impact on our everyday lives, and in particular on the 
discovery of possible cures and treatments. 'Preserving the Brain' also 
demonstrates how critical collaboration and sharing of knowledge are within the 
scientific community. This first international forum could become recurring and 
allow the organizations we are associated with to communicate with a wider 
audience, as they would like to, and Fondazione Prada to contribute tangibly to 
neuroscientific research."

The pivotal moment of "Preserving the Brain" will be the scientific conference 
held on 6 and 7 October 2022, at Fondazione Prada's Cinema in Milan. The 
speakers will explore the subject of neurodegenerative diseases from different 
perspectives, such as genetic implications and molecular mechanisms, clinical 
trials and possible drug treatments. The conference is addressed to researchers 
and universities involved in the project and representatives of prominent 
institutions in the health sector. The sessions will also be streamed and 
visible to all on the online platform:

The exhibition will be held from 16 September to 10 October 2022 in the Podium, 
the space at the center of Fondazione Prada's Milan venue. Conceived by the New 
York studio 2x4, the exhibition design will be divided into different sections 
supervised by the research centers, and a common central area that will 
encourage dialogue and exchanges between the thirteen institutes. Each section 
will examine a specific research process on neurodegenerative diseases 
employing video presentations, technological objects and instruments, 
scientific documents, and visual materials.

Throughout the opening of the exhibition, the 13 institutions participating in 
the project will give a series of online workshops that will be available to 
the public at Each meeting will enable the 
assessment of a specific aspect in the search for new treatments for 
neurodegenerative diseases.

"Preserving the Brain" is realized in collaboration with thirteen of the most 
prestigious international neuroscience institutes and universities: Harvard 
Medical School, Brigham and Women's Hospital, Ann Romney Center for 
Neurological Diseases, Boston, United States; Hôpital de la Pitié-Salpêtrière, 
Sorbonne University AP-HP, Neurology department and Paris Brain Institute, 
Paris, France; UniSR – Università Vita-Salute San Raffaele, Milan, Italy; 
Juntendo University Hospital, Neurology Department, Tokyo, Japan; Karolinska 
Institutet, Stockholm, Sweden; German Center for Neurodegenerative Diseases 
(DZNE) within the Helmholtz Association, Bonn, Germany; Max Planck Institute of 
Neurobiology, Munich, Germany; Montreal Neurological Institute-Hospital, McGill 
Research and Teaching Institute, Canada; Tianjin Medical University General 
Hospital, Neurology Department, Tianjin, China; UCSF Weill Institute for 
Neurosciences, University of California San Francisco, San Francisco, United 
States; University College London, United Kingdom; Weizmann Institute of 
Science, Revohot, Israel; Yale School of Medicine, New Haven, United States.

Media Contact:
+39 02 56 66 26 34


SOURCE: Fondazione Prada